Robert Bindert Huizinga, EVP of Research at Aurinia Pharmaceuticals Inc. (AUPH), sold 130,000 shares at $29.75 ($3.9M) on 2021-10-25, disclosed to the SEC on 2021-10-26.
Open-market sale of $3.9M AUPH by EVP of Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AUPH | SELL | 2021-09-14 | $885K | — | Filing → |
| AUPH | SELL | 2021-09-08 | $92K | — | Filing → |